|
|||||
|
|
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma |
|
| Authors: | Ming Bai Meng Wang Ting Deng Yuxian Bai Kai Zang Zhanhui Miao Wenlin Gai Liangzhi Xie Yi Ba |
| Abstract: | Objective: The mainstay treatment of esophageal squamous cell carcinoma (ESCC) involves chemotherapy and immunotherapy. However, alternative therapies are requi... |
| Keywords: | Epidermal growth factor receptor esophageal squamous cell carcinoma SCT200 monoclonal antibody |